04/15/2026 - Antihistamine Likely Given to Sedate Infant, Inquest Finds


The death of an eight-week-old infant at his family home in west London has been the subject of a formal coronial inquest, culminating in a detailed examination of evidential shortcomings, professional responsibilities, and systemic deficiencies within both investigative practice and the regulation of in-home childcare. The proceedings, presided over by Professor Fiona Wilcox, provide a stark illustration of the legal and evidential complexities that arise in cases of sudden and unexplained infant death.

The inquest concerned the circumstances surrounding the death of the child on 15 January 2024. Evidence established that the infant had been placed under the care of a night nanny during the hours of 9:00pm to 7:00am. At approximately 6:15am, the nanny discovered the child unresponsive in a bassinet. Emergency medical assistance was immediately sought, and resuscitative efforts were undertaken; however, the infant was pronounced deceased at approximately 7:00am.

A post-mortem examination was subsequently conducted, incorporating both pathological assessment and toxicological analysis. The medical cause of death was formally recorded as sudden unexpected death in infancy (SUDI), classified as unexplained. Notwithstanding that classification, toxicological findings revealed the presence of chlorpheniramine, an antihistamine with recognised sedative properties, within the infant’s bloodstream at the time of death.

The court heard expert evidence from practitioners operating within the principal disciplines of Forensic Toxicology, Paediatrics, and Forensic Pathology. These expert witnesses, although not individually identified in the summary findings, provided specialised opinion evidence that proved central to the court’s deliberations.

The toxicological experts established, on the basis of scientific analysis, that chlorpheniramine was present in the infant’s system. They further outlined the pharmacological profile of the substance, noting its capacity to induce sedation through central nervous system depression. Importantly, the experts advised that, while the drug has been associated in certain cases with adverse outcomes in infants, including fatality, the evidential threshold required to conclude that it was the probable cause of death in this instance was not satisfied. The opinion accepted by the court was therefore that chlorpheniramine could have caused or contributed to the infant’s death, but that causation could not be established on the balance of probabilities.

The coroner said: “Evidence was heard that chlorpheniramine causes sedative effects and has been associated with child deaths and should not be administered to a baby this age except on medical advice to treat conditions such as allergy or itch associated with chicken pox infection. It should not be administered to sedate a child.”

Complementary evidence was provided by paediatric specialists, who addressed the clinical appropriateness of administering such a medication to an infant of eight weeks. Their opinion, which was accepted without qualification by the inquiry, was that chlorpheniramine should not be administered to a child of that age in the absence of specific medical indication and professional oversight. In particular, its use as a sedative to induce sleep was characterised as both inappropriate and potentially hazardous. The infant had reportedly been unsettled and prone to waking during the night; however, the experts were unequivocal that such behavioural characteristics did not constitute a legitimate clinical basis for pharmacological intervention.

Forensic pathology evidence further confirmed the absence of any physical trauma, injury, or overt signs of neglect. The pathological findings were consistent with a classification of unexplained infant death, thereby reinforcing the evidential limitations inherent in the case. The convergence of these expert opinions informed the coroner’s ultimate conclusion, namely that while the administration of chlorpheniramine was probable, and medically inappropriate, it could not be determined to have caused the death to the requisite legal standard.

In light of the evidential uncertainties, an open verdict was recorded. Such a conclusion reflects the court’s inability to make a definitive finding as to causation, notwithstanding the presence of suspicious or concerning factors. The legal threshold in coronial proceedings requires that conclusions as to cause be established on the balance of probabilities; where that threshold is not met, the court is constrained to return an open verdict.

A significant aspect of the inquest centred upon the conduct of the initial police investigation. Officers attending the scene undertook what was described as a preliminary assessment, noting the absence of visible injury and the orderly condition of the home environment. On that basis, the circumstances were not treated as suspicious at the material time.

However, the coroner identified a series of investigative omissions that had material evidential consequences. The police failed to conduct a comprehensive search of the premises, including the inspection of bathroom cabinets for medication and the examination of cupboards, drawers, and adjacent rooms. Feeding bottles and associated equipment were not seized, nor were the personal effects of the nanny subjected to forensic scrutiny. These omissions resulted in the loss of potentially probative evidence.

The coroner was particularly critical of the delay in escalating the investigation. The nanny was neither arrested nor formally interviewed until October 2024, by which stage any realistic opportunity to secure forensic corroboration had been irretrievably lost. The report concluded that these failures constituted missed forensic opportunities, which may have been capable of establishing, to the criminal standard, the administration of the drug.

In addressing these deficiencies, the court emphasised the duty of law enforcement authorities to actively exclude the possibility of third-party involvement in cases of unexplained death. The evidence suggested that investigators had been unduly reassured by the superficial presentation of the home environment and had not adequately considered alternative hypotheses, including the potential for inappropriate drug administration.

Beyond the immediate investigative failings, the inquest exposed broader systemic concerns relating to the regulation of in-home childcare. The evidence revealed that the night nanny remained in active employment and was registered with childcare agencies, notwithstanding the court’s finding that she had probably administered chlorpheniramine to the infant. This raised questions as to the adequacy of existing safeguards and oversight mechanisms.

At present, there is no unified statutory framework governing the registration or professional regulation of nannies within the United Kingdom. While certain agencies impose internal standards, these are neither uniform nor mandatory. The coroner expressed concern that this regulatory lacuna permits individuals to operate in positions of significant responsibility without consistent training, accreditation, or accountability.

In her Prevention of Future Deaths report, Professor Wilcox advanced a series of recommendations aimed at mitigating the risk of recurrence. These included the enhancement of police training and operational guidance to ensure that all cases of sudden infant death are subject to thorough and systematic investigation, irrespective of initial appearances. Particular emphasis was placed on the need to preserve potential evidence, including feeding equipment, pending the outcome of toxicological analysis.

The report further recommended the introduction of targeted training for childcare providers, specifically addressing the administration of medication to infants. It was suggested that nannies should be explicitly instructed that substances containing chlorpheniramine must not be administered without medical advice and the informed consent of parents. Such training would serve to clarify professional boundaries and reduce the likelihood of inappropriate intervention.

Additionally, the coroner raised concerns regarding the adequacy of consumer warnings associated with over-the-counter antihistamines. It was proposed that labelling and public information be reviewed to ensure that the risks of administering such medications to very young children are clearly and prominently communicated.

The case also forms part of a broader pattern identified in contemporaneous inquests, in which concerns have been raised regarding the use of professional titles within the childcare sector. In particular, the designation “maternity nurse” has been criticised as potentially misleading, insofar as it may imply a level of medical qualification or expertise that is not, in fact, required.

From a legal perspective, the inquest underscores the critical importance of early evidential preservation, the proper application of investigative protocols, and the reliance upon appropriately qualified expert witnesses. The interplay between forensic toxicology, paediatrics, and forensic pathology was central to the court’s analysis, even though the ultimate conclusion remained constrained by evidential insufficiency.

*Note ai definition: Chlorpheniramine is a first-generation antihistamine used to treat allergies but notable for its sedative effects, as it crosses the blood–brain barrier and depresses the central nervous system. This makes it unsuitable for infants unless prescribed, and it must never be used to induce sleep. In contrast, second-generation antihistamines such as Loratadine and Cetirizine are designed to be less sedating, with reduced penetration into the brain. Third-generation variants, including Fexofenadine, offer even greater specificity and fewer side effects. In the case examined, experts concluded chlorpheniramine could have contributed to death, but causation was not proven.

by Edward Price

https://pubmed.ncbi.nlm.nih.gov/11235817/

https://witnessdirectory.com/signup.php